Bangladesh Pharmaceutical Society (BPS)
Bangladesh Association of Pharmaceutical Industries (BAPI)
Pharmacy Graduates' Association (PGA), Bangladesh
Bangladesh Pharmacy Students Association (BPSA)
Friday, June 26, 2009
Pharma Organizations in Bangladesh
Pharma Organizations in Bangladesh
Bangladesh Pharmaceutical Society (BPS)
Bangladesh Association of Pharmaceutical Industries (BAPI)
Pharmacy Graduates' Association (PGA), Bangladesh
Bangladesh Pharmacy Students Association (BPSA)
Pharma Organizations in Bangladesh
Bangladesh Pharmaceutical Society (BPS)
Bangladesh Association of Pharmaceutical Industries (BAPI)
Pharmacy Graduates' Association (PGA), Bangladesh
Bangladesh Pharmacy Students Association (BPSA)
Bangladesh Becomes Global Hub of Medicines
Mar. 25, 2009 (The Korea Times) — The pharmaceutical sector in Bangladesh, one of the fastest growing sectors of the economy, is poised to transform the country into a global hub of quality medicines.
The $700 million sector with more than 230 manufacturers is continuously expanding with new products to new international destinations.
The export value of pharmaceuticals is small but growing at 50 percent per year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007, while export destinations climbed from 37 countries to 72 during the period.
The industry’s inception dates back to the 1950s when a few multinationals and local entrepreneurs started with manufacturing facilities in the then East Pakistan.
By 1982, many top ranking multinationals established their manufacturing facilities in this part of the world. Prominent among them were Pfizer (NYSE:PFE) , Glaxo, Fisons, Squibb, Hoechst, ICI, May & Baker and Organon. Read more
The $700 million sector with more than 230 manufacturers is continuously expanding with new products to new international destinations.
The export value of pharmaceuticals is small but growing at 50 percent per year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007, while export destinations climbed from 37 countries to 72 during the period.
The industry’s inception dates back to the 1950s when a few multinationals and local entrepreneurs started with manufacturing facilities in the then East Pakistan.
By 1982, many top ranking multinationals established their manufacturing facilities in this part of the world. Prominent among them were Pfizer (NYSE:PFE) , Glaxo, Fisons, Squibb, Hoechst, ICI, May & Baker and Organon. Read more
Bangladesh Becomes Global Hub of Medicines
Mar. 25, 2009 (The Korea Times) — The pharmaceutical sector in Bangladesh, one of the fastest growing sectors of the economy, is poised to transform the country into a global hub of quality medicines.
The $700 million sector with more than 230 manufacturers is continuously expanding with new products to new international destinations.
The export value of pharmaceuticals is small but growing at 50 percent per year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007, while export destinations climbed from 37 countries to 72 during the period.
The industry’s inception dates back to the 1950s when a few multinationals and local entrepreneurs started with manufacturing facilities in the then East Pakistan.
By 1982, many top ranking multinationals established their manufacturing facilities in this part of the world. Prominent among them were Pfizer (NYSE:PFE) , Glaxo, Fisons, Squibb, Hoechst, ICI, May & Baker and Organon. Read more
The $700 million sector with more than 230 manufacturers is continuously expanding with new products to new international destinations.
The export value of pharmaceuticals is small but growing at 50 percent per year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007, while export destinations climbed from 37 countries to 72 during the period.
The industry’s inception dates back to the 1950s when a few multinationals and local entrepreneurs started with manufacturing facilities in the then East Pakistan.
By 1982, many top ranking multinationals established their manufacturing facilities in this part of the world. Prominent among them were Pfizer (NYSE:PFE) , Glaxo, Fisons, Squibb, Hoechst, ICI, May & Baker and Organon. Read more
Bangladesh Becomes Global Hub of Medicines
Mar. 25, 2009 (The Korea Times) — The pharmaceutical sector in Bangladesh, one of the fastest growing sectors of the economy, is poised to transform the country into a global hub of quality medicines.
The $700 million sector with more than 230 manufacturers is continuously expanding with new products to new international destinations.
The export value of pharmaceuticals is small but growing at 50 percent per year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007, while export destinations climbed from 37 countries to 72 during the period.
The industry’s inception dates back to the 1950s when a few multinationals and local entrepreneurs started with manufacturing facilities in the then East Pakistan.
By 1982, many top ranking multinationals established their manufacturing facilities in this part of the world. Prominent among them were Pfizer (NYSE:PFE) , Glaxo, Fisons, Squibb, Hoechst, ICI, May & Baker and Organon. Read more
The $700 million sector with more than 230 manufacturers is continuously expanding with new products to new international destinations.
The export value of pharmaceuticals is small but growing at 50 percent per year. Exports increased from $8.2 million in 2004 to $28.3 million in 2007, while export destinations climbed from 37 countries to 72 during the period.
The industry’s inception dates back to the 1950s when a few multinationals and local entrepreneurs started with manufacturing facilities in the then East Pakistan.
By 1982, many top ranking multinationals established their manufacturing facilities in this part of the world. Prominent among them were Pfizer (NYSE:PFE) , Glaxo, Fisons, Squibb, Hoechst, ICI, May & Baker and Organon. Read more
Beximco Pharma Is First Pharmaceutical Company From Bangladesh To EnterLatin America
Beximco Pharmaceuticals Ltd., the leading edge pharmaceutical manufacturer and the largest pharmaceutical exporter of Bangladesh has commenced exports to Chile, after receiving marketing authorization for a number of products from "Instituto de Salud Publica de Chile" (Drug Regulatory authority in Chile). With this, BPL has become the first Bangladeshi pharmaceutical company to obtain product registration in any Latin American country, a company statement said today. Read more
Beximco Pharma Is First Pharmaceutical Company From Bangladesh To EnterLatin America
Beximco Pharmaceuticals Ltd., the leading edge pharmaceutical manufacturer and the largest pharmaceutical exporter of Bangladesh has commenced exports to Chile, after receiving marketing authorization for a number of products from "Instituto de Salud Publica de Chile" (Drug Regulatory authority in Chile). With this, BPL has become the first Bangladeshi pharmaceutical company to obtain product registration in any Latin American country, a company statement said today. Read more
Beximco Pharma Is First Pharmaceutical Company From Bangladesh To EnterLatin America
Beximco Pharmaceuticals Ltd., the leading edge pharmaceutical manufacturer and the largest pharmaceutical exporter of Bangladesh has commenced exports to Chile, after receiving marketing authorization for a number of products from "Instituto de Salud Publica de Chile" (Drug Regulatory authority in Chile). With this, BPL has become the first Bangladeshi pharmaceutical company to obtain product registration in any Latin American country, a company statement said today. Read more
APE2009 showcases Bangladesh pharma market
Asia Pharma Expo 2009 (APE2009), the international exhibition for South Asian pharmaceutical market was conducted on January 22 to 24, 2009 at Bangladesh China Friendship Conference Center, Dhaka. The three-day international event saw exhibiting companies from 18 countries exhibit their technology. The event was supported by the Export Promotion Bureau--Bangladesh, endorsed by the Engineering Export Promotion Council (EEPC-INDIA), Pharmaceutical Export Promotion Council (Pharmexcil), India, and Bulk Drug Manufacturers Association, (BDMA), India. It was sponsored by two of the largest pharma giants of the region: Eskayef Bangladesh and Beximco Pharmaceuticals. Read more
APE2009 showcases Bangladesh pharma market
Asia Pharma Expo 2009 (APE2009), the international exhibition for South Asian pharmaceutical market was conducted on January 22 to 24, 2009 at Bangladesh China Friendship Conference Center, Dhaka. The three-day international event saw exhibiting companies from 18 countries exhibit their technology. The event was supported by the Export Promotion Bureau--Bangladesh, endorsed by the Engineering Export Promotion Council (EEPC-INDIA), Pharmaceutical Export Promotion Council (Pharmexcil), India, and Bulk Drug Manufacturers Association, (BDMA), India. It was sponsored by two of the largest pharma giants of the region: Eskayef Bangladesh and Beximco Pharmaceuticals. Read more
APE2009 showcases Bangladesh pharma market
Asia Pharma Expo 2009 (APE2009), the international exhibition for South Asian pharmaceutical market was conducted on January 22 to 24, 2009 at Bangladesh China Friendship Conference Center, Dhaka. The three-day international event saw exhibiting companies from 18 countries exhibit their technology. The event was supported by the Export Promotion Bureau--Bangladesh, endorsed by the Engineering Export Promotion Council (EEPC-INDIA), Pharmaceutical Export Promotion Council (Pharmexcil), India, and Bulk Drug Manufacturers Association, (BDMA), India. It was sponsored by two of the largest pharma giants of the region: Eskayef Bangladesh and Beximco Pharmaceuticals. Read more
About Bangladesh Pharma Industry
In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which is contributing in the country's economy. After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. The professional knowledge, thoughts and innovative ideas of the pharmacists working in this sector are the key factors for this developments. Due to recent development of this sector it is exporting medicines to global market including European market. This sector is also providing 97% of the total medicine requirement of the local market. Leading pharmaceutical companies like Eskayef Bangladesh Limited, Square Pharmaceuticals Limited, Beximco Pharmaceuticals Limited and many more are expanding their business with the aim to expand export market which is also rapidly growing.
About Bangladesh Pharma Industry
In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which is contributing in the country's economy. After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. The professional knowledge, thoughts and innovative ideas of the pharmacists working in this sector are the key factors for this developments. Due to recent development of this sector it is exporting medicines to global market including European market. This sector is also providing 97% of the total medicine requirement of the local market. Leading pharmaceutical companies like Eskayef Bangladesh Limited, Square Pharmaceuticals Limited, Beximco Pharmaceuticals Limited and many more are expanding their business with the aim to expand export market which is also rapidly growing.
About Bangladesh Pharma Industry
In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which is contributing in the country's economy. After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. The professional knowledge, thoughts and innovative ideas of the pharmacists working in this sector are the key factors for this developments. Due to recent development of this sector it is exporting medicines to global market including European market. This sector is also providing 97% of the total medicine requirement of the local market. Leading pharmaceutical companies like Eskayef Bangladesh Limited, Square Pharmaceuticals Limited, Beximco Pharmaceuticals Limited and many more are expanding their business with the aim to expand export market which is also rapidly growing.
Regulatory Authorities
Two organizations, one government (Directorate of Drug Administration ) and one semi-government (Pharmacy Council of Bangladesh), control pharmacy practice in Bangladesh. The Bangladesh Pharmaceutical Society is affiliated with international organizations International Pharmaceutical Federation and Commonwealth Pharmaceutical Association.
Regulatory Authorities
Two organizations, one government (Directorate of Drug Administration ) and one semi-government (Pharmacy Council of Bangladesh), control pharmacy practice in Bangladesh. The Bangladesh Pharmaceutical Society is affiliated with international organizations International Pharmaceutical Federation and Commonwealth Pharmaceutical Association.
Regulatory Authorities
Two organizations, one government (Directorate of Drug Administration ) and one semi-government (Pharmacy Council of Bangladesh), control pharmacy practice in Bangladesh. The Bangladesh Pharmaceutical Society is affiliated with international organizations International Pharmaceutical Federation and Commonwealth Pharmaceutical Association.
Tuesday, June 23, 2009
Bangladesh Pharma: Waiting in the wings
Thursday, January 27, 2005 08:00 IST
By A Correspondent
Pharmaceutical Industry has grown in Bangladesh in the last two decades at a considerable rate. Currently estimated at US $ 482 million (IMS), the industry may look smaller compared to the population size of 124 million. There are nearly 200 manufacturers who together make about 95% of the formulations required for the country. Growing at an average rate of 9%, the formulation industry offers tremendous potential.Local firms manufacture about 6,000 brands of medicines in different dosage forms. read more
Bangladesh Pharma: Waiting in the wings
Thursday, January 27, 2005 08:00 IST
By A Correspondent
Pharmaceutical Industry has grown in Bangladesh in the last two decades at a considerable rate. Currently estimated at US $ 482 million (IMS), the industry may look smaller compared to the population size of 124 million. There are nearly 200 manufacturers who together make about 95% of the formulations required for the country. Growing at an average rate of 9%, the formulation industry offers tremendous potential.Local firms manufacture about 6,000 brands of medicines in different dosage forms. read more
Bangladesh Pharma: Waiting in the wings
Thursday, January 27, 2005 08:00 IST
By A Correspondent
Pharmaceutical Industry has grown in Bangladesh in the last two decades at a considerable rate. Currently estimated at US $ 482 million (IMS), the industry may look smaller compared to the population size of 124 million. There are nearly 200 manufacturers who together make about 95% of the formulations required for the country. Growing at an average rate of 9%, the formulation industry offers tremendous potential.Local firms manufacture about 6,000 brands of medicines in different dosage forms. read more
Subscribe to:
Comments (Atom)